EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Magnesium biology

Jana L Kröse, Jeroen H F de Baaij iD

Nephrology Dialysis Transplantation · 27.11.2024 · 39 (12) · 1965-1975

DOI: 10.1093/ndt/gfae134 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 13.06.2024. Verfasst von Jana L Kröse und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical BioSciences, Radboudumc, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Magnesium. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Kidney Foundation, Netherlands Organization for Scientific Research, European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Magnesium (Mg2+) is essential for energy metabolism, muscle contraction and neurotransmission. As part of the Mg–ATP complex, it is involved in over 600 enzymatic reactions. Serum Mg2+ levels are tightly regulated between 0.7 and 1.1 mmol/L by interplay of intestinal absorption and renal excretion. In the small intestine, Mg2+ is absorbed paracellularly via claudin-2 and -12. In the colon, transcellular absorption of Mg2+ is facilitated by TRPM6/7 and CNNM4. In the kidney, the proximal tubule reabsorbs only 20% of the filtered Mg2+. The majority of the filtered Mg2+ is reabsorbed in the thick ascending limb, where the lumen-positive transepithelial voltage drives paracellular transport via claudin-16/-19. Fine-tuning of Mg2+ reabsorption is achieved in the distal convoluted tubule (DCT). Here, TRPM6/7 tetramers facilitate apical Mg2+ uptake, which is hormonally regulated by insulin and epidermal growth factor. Basolateral Mg2+ extrusion is Na+ dependent and achieved by CNNM2 and/or SLC41A3. Hypomagnesemia (serum Mg2+ <0.7 mmol/L) develops when intestinal and/or renal Mg2+ (re)absorption is disturbed. Common causes include alcoholism, type 2 diabetes mellitus and the use of pharmacological drugs, such as proton-pump inhibitors, calcineurin inhibitors and thiazide diuretics. Over the last decade, research on rare genetic and acquired Mg2+ disorders have identified Mg2+ channel and transporter activity, DCT length, mitochondrial function and autoimmunity as mechanisms explaining hypomagnesemia. Classically, treatment of hypomagnesemia depended on oral or intravenous Mg2+ supplementation. Recently, prebiotic dietary fibers and sodium-glucose cotransporter 2 inhibitors have been proposed as promising new therapeutic pathways to treat hypomagnesemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MagnesiumHumansAnimalsIntestinal AbsorptionMagnesium Deficiency

Stichwörter der Autor:innen

SGLT2 inhibitorsdrug-induced hypomagnesemiahypomagnesemiamagnesium homeostasismagnesium pathophysiology

Substanzen

Magnesium

Autor:innen und Institutionen

  • Department of Medical BioSciences, Radboudumc, Nijmegen, The Netherlands.

ORCID-Profile: Jeroen H F de Baaij

Förderung

  • Dutch Kidney Foundation
  • Netherlands Organization for Scientific Research
  • European Research Council

Zitieren

APA

Kröse, J. L., & de Baaij, J. H. F. (2024). Magnesium biology. Nephrology Dialysis Transplantation, 39(12), 1965-1975. https://doi.org/10.1093/ndt/gfae134

Vancouver

Kröse JL, de Baaij JHF. Magnesium biology. Nephrology Dialysis Transplantation. 2024;39(12):1965-1975. doi:10.1093/ndt/gfae134

BibTeX
@article{Krse2024,
  author = {Kröse, Jana L and de Baaij, Jeroen H F},
  title = {Magnesium biology},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  volume = {39},
  number = {12},
  pages = {1965--1975},
  doi = {10.1093/ndt/gfae134}
}
Kostenlos starten →